The global companion animal veterinary vaccines market size is expected to grow from $3.05 billion in 2021 to $3.25 billion in 2022 at a compound annual growth rate (CAGR) of 6.7%. The global companion animal veterinary vaccine market size is expected to grow to $4.19 billion in 2026 at a CAGR of 6.6%.
What is the Global Companion Animal Veterinary Vaccines Market?
The companion animal veterinary vaccines market consists of sales of companion animal vaccines by entities (organizations, sole traders, and partnerships) that manufacture companion animal vaccines. Companion animal vaccines are substances that are used to stimulate the production of antibodies and provide immunity against one or several diseases in pets such as dogs, birds, and cats. Only goods and services traded between entities or sold to end consumers are included.
Get a Sample of the global companion animal veterinary vaccines market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=3370&type=smp
What drives the Global Companion Animal Veterinary Vaccines Market?
Increased pet ownership by Gen X and Gen Y adults contributed to the growth of the companion animal veterinary vaccines market during the historic period. According to the APPA, millennials, or Gen Y represents the largest segment of pet owners for all types of pets. More than 80% of Gen Y and Gen Z own a dog and 50% or less own a cat as a pet. Multiple pet ownership is also on the rise in some parts of the world. According to the 2019-2020 APPA National Pet Owners Survey, 67% of US households own pets, which is equal to 84.9 million homes. Pet owners are well aware of advanced facilities and are willing to spend a large amount of money on the health of their pets. Therefore, the rise in pet ownership aids in the growth of the companion animal veterinary vaccines market.
Get the full global companion animal veterinary vaccines industry report here
https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report
Global Companion Animal Veterinary Vaccines Market Segments
The global companion animal veterinary vaccines market is segmented:
By Product: Inactivated, Live Attenuated, Recombinant, Others
By Route of Administration: Oral, Parenteral, Others
By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores, Others
By Geography: The regions covered in the companion animal veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Companion Animal Veterinary Vaccines Global Market Report 2022provides market size and growth forecasts for the global companion animal veterinary vaccines market, global companion animal veterinary vaccines market share, companion animal veterinary vaccines market segments and geographies, companion animal veterinary vaccines market competitive landscape including leading competitors’ revenues, profiles and market shares. The companion animal veterinary vaccines market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Companion Animal Veterinary Vaccines Industry Playersinclude Boehringer Ingelheim, Eli Lilly and Company (Elcano), Heska Co., Merck Animal Health, Virbac, Zoetis, ElancoCeva Sante Animal S.A., Bayer Healthcare, NEOGEN CORPORATION, and ImmuCell Corporation. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
